The choice of auxiliary substances to obtain sublingual glycin tablets with thiotriazoline with direct compaction method Reporting 1. Study of the influence of excipients on the bulk density, the bulk density after shrinkage, the fluidity and the angle o
DOI:
https://doi.org/10.14739/2409-2932.2020.1.198182Keywords:
glycine, thiotriazoline, tablets, excipientsAbstract
Today in Ukraine, stroke remains the second and most common cause of premature mortality and disability. More than 111.000 new cases of stroke occur every year in Ukraine. This is a very topical medical and social problem worldwide. Today, a promising area of primary neuroprotection in cerebral ischemia is to correct the imbalance of excitatory and inhibitory neurotransmitter systems through the activation of natural inhibitory processes. Our attention was drawn to the natural inhibitory neurotransmitter glycine and its role in the mechanisms of acute cerebral ischemia. There is evidence of the ability of the thiotriazoline antioxidant to potentiate the therapeutic effect of neurometabolic cerebroprotectors. Based on this, we have created a new combination drug based on glycine with thiotriazoline. For the new combination drug, a rational dosage form of the tablet was selected.
The purpose of this work is to select excipients for producing glycine tablets with thiotriazoline by direct compression, to study their effect on bulk density, bulk density after shrinkage, fluidity, and angle of natural inclination.
Materials and methods. The studies were used: glycine (manufacturer: China); Thiotriazoline (manufacturer: State Enterprise Chemical Reagents Plant of the Institute of monocrystals of the NAS of Ukraine), certified excipients based on microcrystalline cellulose, granulated sugars, granulated inorganic salts, lubricating as well as domestic.
At first, morphometric studies of glycine powders, thiotriazoline, and mixtures of glycine with thiotriazoline were conducted. In the course of the work, four groups of excipients, factors, and their levels were studied. To study the four qualitative factors, we used the Greek-Latin square 4 × 4. The bulk density, the bulk density after shrinkage, the fluidity, and the angle of the natural slope of the glycine powder masses with thiotriazoline were studied.
Results. According to the results of the experimental studies, the variance analysis of the experimental data was carried out and conclusions were drawn about the influence of the studied factors on the quality parameters of the glycine powder masses with thiotriazoline
Conclusions. In the course of the researches, the influence of four groups of excipients on the bulk density, the bulk density after shrinkage, the fluidity, the angle of the natural slope of the glycine powder masses with thiotriazoline were studied. According to the results of the analysis of variance, optimum auxiliaries were selected which provide quality according to the studied parameters.
References
Mazur, I. A., Chekman, I. S, & Belenichev, I. F. (2007). Metabolitotropnye preparaty [Metabolithotropic Drugs]. Zaporozhye. [in Russian].
Kucherenko, L., Khomylova, O., & Levykh, A. (2016). Primenenie neirotransmitternykh aminokislot v sovremennoi meditsine [Use of neurotransmitter aminoacids in modern medicine]. Retsept, 19(5), 616-620. [in Russian].
Bielenichev, I. F., Mazur, I. A., Voloshyn, M. A., Horchakova, N. O., & Chekman, I. S. (2007). Mekhanizm protyishemichnoi ta antyoksydantnoi dii tiotryazolinu [The mechanism of antioxidant and anti-ischemic action of thiotriazolin]. Novosti meditsiny i farmatsii, 2, 8-9. [in Ukrainian].
Mazur, I. A., Voloshin, N. A., Chekman, I. S., Zimenkovskii, B. S., & Stets, V. R. (2005). Tiotriazolin: farmakologicheskie aspekty i klinicheskoe primenenie [Thiotriazoline: pharmacological aspects and clinical usage]. Zaporozhye; Lvov: Nautіlus.
Mazur, I. A., Chekman, I. S., Belenichev, I. F., & Kucherenko, L. I. (2011). Razrabotka lekarstvennykh sredstv na osnove fiksirovannykh kombinatsii s antioksidantami - perspektivnoe napravlenie sovremennoi farmakologii [The development of medicines based on fixed combinations with antioxidants is a promising area of modern pharmacology]. Farmakolohiia ta likarska toksykolohiia, 5, 199-200. [in Russian].
Kucherenko, L. I., Khomylova, O. V., Mazur, І. А., Belenichev, I. F., & Horbacheva, S. V. (2017). Ukrainian Patent No. 114270. Kombinovanyi likarskyi zasib dlia pervynnoi neiroprotektsii [Combination drug for primary neuroprotection]. Retrieved from https://base.uipv.org/searchINV/search.php?action=viewdetails&IdClaim=235074
Kucherenko, L., Belenichev, I., Mazur, I., Khromylova, O., & Parniuk, N. (2018). Influence of the fixed combination of glycine with thiotriazoline on energy metabolism parameters in brain in conditions of experimental cerebral ischemia. Ankara Universitesi Eczacilik Fakultesi Dergisi, 42(1), 14-21. https://doi.org/10.1501/Eczfak-0000000598
Kucherenko, L. I., & Khromyliova, O. V. (2014). Vybir dopomizhnykh rechovyn z metoiu otrymannia tabletok izoniazydu z tiotryazolinom metodom priamoho presuvannia [Choice of adjuvants for the preparation of the tablets with isoniazid and thiotriasolin by direct compression method]. Farmatsevtychnyi chasopys, 1, 80-84. [in Ukrainian].
Hroshovyi, T. A., Martseniuk, V. P., Kucherenko, L. I., Vronska, L. P., & Hureieva, S. M. (2008). Matematychne planuvannia eksperymentu pry provedenni naukovykh doslidshen v farmatsii [The mathematical planning of experiment is during realization of scientific researches in pharmacya]. Ternopil: TDMU. [in Ukrainian].
(2014). Derzhavna Farmakopeya Ukrayiny [The State Pharmacopoeia of Ukraine] (2nd ed.). Vol. 1. Kharkiv: State Enterprise Ukrainian Scientific Pharmacopoeial Center of Medicines Quality. [in Ukrainian].
Downloads
How to Cite
Issue
Section
License
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access)
